Assembly Biosciences (ASMB) Operating Expenses (2010 - 2026)
Assembly Biosciences (ASMB) posted quarterly Operating Expenses of $19.6 million for Q1 2026, up 1.15% year-over-year from $19.4 million in Q1 2025, and down 13.62% quarter-over-quarter from $22.7 million in Q4 2025.
Assembly Biosciences (ASMB) Operating Expenses (2010 - 2026) Analysis & Trends
Assembly Biosciences' Operating Expenses history runs 17 years deep, the most recent figure standing at $19.6 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 1.15% year-over-year to $19.6 million; the TTM figure through Mar 2026 stood at $84.6 million (up 10.23% YoY), while the FY2025 annual figure was $84.4 million, up 14.18% from the prior year.
- Operating Expenses for Q1 2026 stood at $19.6 million, down from $22.7 million in the prior quarter.
- The five-year high for Operating Expenses was $24.6 million in Q2 2022, with the low at $15.0 million in Q3 2023.
- The 5-year median for Operating Expenses is $19.7 million (2023), against an average of $20.2 million.
- The sharpest annual moves came in 2022 and 2025: Operating Expenses tumbled 63.46% in 2022, then gained 21.75% in 2025.
- Assembly Biosciences' Operating Expenses stood at $23.0 million in 2022, then declined by 14.2% to $19.7 million in 2023, then dropped by 4.18% to $18.9 million in 2024, then gained by 20.02% to $22.7 million in 2025, then decreased by 13.62% to $19.6 million in 2026.
- Business Quant data shows ASMB's Operating Expenses at $19.6 million in Q1 2026, $22.7 million in Q4 2025, and $21.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 19.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.72 Mn |
| Mar 31, 2026 | 19.58 Mn |
| Dec 31, 2025 | 22.67 Mn |
| Sep 30, 2025 | 21.67 Mn |
| Jun 30, 2025 | 20.72 Mn |
| Mar 31, 2025 | 19.36 Mn |
| Dec 31, 2024 | 18.89 Mn |
| Sep 30, 2024 | 17.80 Mn |
| Jun 30, 2024 | 20.74 Mn |
| Mar 31, 2024 | 16.51 Mn |
| Dec 31, 2023 | 19.71 Mn |
| Sep 30, 2023 | 15.05 Mn |
| Jun 30, 2023 | 17.49 Mn |
| Mar 31, 2023 | 19.56 Mn |
| Dec 31, 2022 | 22.98 Mn |
| Sep 30, 2022 | 23.40 Mn |
| Jun 30, 2022 | 24.57 Mn |
| Mar 31, 2022 | 23.16 Mn |
| Dec 31, 2021 | 62.89 Mn |
| Sep 30, 2021 | 25.13 Mn |